Clinical Trials Browser

Phase 2 × Multiple Myeloma × COH04S1 COVID-19 vaccine × Clear all

NCT04977024 2026-02-11

SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer

Phase 2 Active not recruiting

LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Leukemia, Lymphoma, Multiple Myeloma